(Q77815303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Evaluation of microspheres containing cytokine neutralizing antibodies in endotoxemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

M J D'Souza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C W Oettinger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G V Milton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

Drug Development and Industrial Pharmacy

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

727-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

Radioactive albumin microspheres for studies of the pulmonary circulation

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Prolongation of murine cardiac allograft survival by microspheres containing TNF alpha and IL1-beta neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100102232

21 January 2018

Identifiers

DOI

10.1081/DDC-100102232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10349558%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference